Skip to main content
SpringerLink
Log in

Behandlung der Patientin mit schlechtem Ansprechen auf die ovarielle Stimulation

  • Chapter
Reproduktionsmedizin

  • 4241 Accesses

Zusammenfassung

Einen wesentlichen Anteil an der Effizienz des IVF-Verfahrens hat die hormonelle Stimulation mit dem Ziel der Gewinnung mehrerer entwicklungsfähiger Eizellen. Eine durchschnittliche Befruchtungsrate von 55–64% nach IVF und ICSI macht die Verfügbarkeit mehrerer Eizellen zur Voraussetzung, um regelhaft zumindest einen Embryo für die Übertragung in die Gebärmutter zur Verfügung zu haben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Barad DH, Gleicher N (2005) Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 84 (3): 756. PubMed PMID: 16169414

    Google Scholar 

  • Barad D, Gleicher N (2006) Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 21 (11): 2845–2849

    Article  PubMed  CAS  Google Scholar 

  • Bar-Hava I, Ferber A, Ashkenazi J, Dicker D, Ben-Rafael Z, Orvieto R (2000) Natural- ycle in vitro fertilization in women aged over 44 years. Gynecol Endocrinol 14: 248–252

    Article  PubMed  CAS  Google Scholar 

  • Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL (1998) Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin- releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 70 (6): 1063–1069

    Article  PubMed  CAS  Google Scholar 

  • Blockeel C, Engels S, De Vos M, Haentjens P, Polyzos NP, Stoop D, Camus M, Devroey P (2012) Oestradiol valerate pretreatment in GnRH-antagonist cycles: a  andomized controlled trial. Reprod Biomed Online 24 (3): 272–280

    Article  PubMed  CAS  Google Scholar 

  • Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L, Tarlatzis BC (2012) The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 18 (2): 127–145

    Article  PubMed  CAS  Google Scholar 

  • Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE (2000) Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 15: 2129–2132

    Article  PubMed  CAS  Google Scholar 

  • Feldman B, Seidman DS, Levron J, Bider D, Shulman A, Shine S, Dor J (2001) In vitro fertilization following natural cycles in poor responders. Gynecol Endocrinol 15 (5): 328–334

    PubMed  CAS  Google Scholar 

  • Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L (2011) ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ›poor response‹ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26 (7): 1616–1624

    Article  PubMed  CAS  Google Scholar 

  • Gelbaya TA, Tsoumpou I, Nardo LG (2010) The likelihood of live birth and multiple birth after single versus double embryo transfer at the cleavage stage: a systematic review and meta-analysis. Fertil Steril 94 (3): 936–945

    Article  PubMed  Google Scholar 

  • Gleicher N, Weghofer A, Barad DH (2010) Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online 21 (3): 360–365

    Article  PubMed  CAS  Google Scholar 

  • Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM (2006) GnRHantagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online 13 (5): 628–638

    Article  PubMed  CAS  Google Scholar 

  • Griesinger G, Kolibianakis EM, Venetis C, Diedrich K, Tarlatzis B (2010) Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. Fertil Steril 94 (6): 2382–2384

    Article  PubMed  CAS  Google Scholar 

  • Guivarc’h-Levêque A, Homer L, Arvis P, Broux PL, Moy L, Priou G, Vialard J, Colleu D, Dewailly D (2011) Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes? Fertil Steril 96 (4): 872–876

    Article  PubMed  Google Scholar 

  • Hill MJ, Levens ED, Levy G, Ryan ME, Csokmay JM, Decherney AH, Whitcomb BW (2012) The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertil Steril 97 (5): 1108–1114.e1

    Article  PubMed  CAS  Google Scholar 

  • Kadoch IJ, Al-Khaduri M, Phillips SJ, Lapensée L, Couturier B, Hemmings R, Bissonnette F (2008) Spontaneous ovulation rate before oocyte retrieval in modified natural cycle IVF with and without indomethacin. Reprod Biomed Online 16 (2): 245–249

    Article  PubMed  Google Scholar 

  • Kadoch IJ, Phillips SJ, Bissonnette F (2011) Modified natural-cycle in vitro fertilization should bevconsidered as the first approach in young poor responders. Fertil Steril 96 (5): 1066–1068

    Article  PubMed  Google Scholar 

  • Kawachiya S, Matsumoto T, Bodri D, Kato K, Takehara Y, Kato O (2012) Short-term, low-dose, non-steroidal anti-inflammatory drug application diminishes premature ovulation in natural-cycle IVF. Reprod Biomed Online 24 (3): 308–313

    Article  PubMed  CAS  Google Scholar 

  • Kim CH, Jeon GH, Cheon YP, Jeon I, Kim SH, Chae HD, Kang BM (2009) Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection. Fertil Steril 92: 1758–1760

    Article  PubMed  Google Scholar 

  • Kim CH, Howles CM, Lee HA (2011) The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril 95 (2): 679–683

    Article  PubMed  CAS  Google Scholar 

  • Klinkert ER, Broekmans FJ, Looman CW, Habbema JD, te Velde ER (2005) Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod 20 (3): 611–615

    Article  PubMed  CAS  Google Scholar 

  • Kolibianakis E, Zikopoulos K, Camus M, Tournaye H, Van Steirteghem A, Devroey P (2004) Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. Hum Reprod 19 (11): 2545–2549

    Article  PubMed  Google Scholar 

  • Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G (2006) Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update 12 (6): 651–671

    Article  PubMed  CAS  Google Scholar 

  • Kolibianakis EM, Kalogeropoulou L, Griesinger G, Papanikolaou EG, Papadimas J, Bontis J, Tarlatzis BC (2007) Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. Hum Reprod Update 13 (5): 445–452

    Article  PubMed  CAS  Google Scholar 

  • Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G (2009) Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update 15 (6): 613–622

    Article  PubMed  CAS  Google Scholar 

  • Kolibianakis EM, Venetis CA, und Tarlatzis BC (2011) DHEA administration in poor responders Hum. Reprod 26 (3): 730–731

    CAS  Google Scholar 

  • Lekamge DN, Lane M, Gilchrist RB, Tremellen KP (2008) Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet Nov-Dec) 25 (11–12): 515–521. Epub 2008 Oct 30. PubMed PMID: 18972201

    Google Scholar 

  • Lossl K, Andersen CY, Loft A, Freiesleben NL, Bangsbøll S, Andersen AN (2008) Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod 23 (8): 1820–1829

    Article  PubMed  CAS  Google Scholar 

  • Massin N, Cedrin-Durnerin I, Coussieu C, Galey-Fontaine J, Wolf JP, Hugues JN (2006) Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique – a prospective,randomized, double-blind study. Hum Reprod 21 (5): 1204–1211

    Article  PubMed  CAS  Google Scholar 

  • Mochtar MH, Van der Veen, Ziech M, van Wely M (2007) Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev 18 (2): CD005070

    Google Scholar 

  • Nielsen ME, Rasmussen IA, Kristensen SG, Christensen ST, Møllgård K, Wreford, Andersen E, Byskov AG, Yding Andersen C (2011) In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA. Mol Hum Reprod 17 (1): 63–70

    Article  PubMed  CAS  Google Scholar 

  • Pandian Z, McTavish AR, Aucott L, Hamilton MP, Bhattacharya S (2010) Interventions for ›poor responders‹ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 20 (1): CD004379

    Google Scholar 

  • Pu D, Wu J, Liu J (2011) Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod 26 (10): 2742–2749, Erratum in: Hum Reprod (2012) 27 (4):1230

    Article  PubMed  CAS  Google Scholar 

  • Schimberni M, Morgia F, Colabianchi J, Giallonardo A, Piscitelli C, Giannini P, Montigiani M, Sbracia M (2009) Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. Fertil Steril 92 (4): 1297–1301

    Article  PubMed  Google Scholar 

  • Sen A, Hammes SR (2010) Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol 24 (7): 1393–1403

    Article  PubMed  CAS  Google Scholar 

  • Tutuncu L, Dundar O (2012) Increasing the stimulation dose of rfsh in unexpected poor responders is not associated with better IVF outcome. The ScientificWorld Journal Volume 2012, Article ID 202804 doi: 10.1100/2012/202804

    Google Scholar 

  • Van Hooff MH, Alberda AT, Huisman GJ, Zeilmaker GH, Leerentveld RA (1993) Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod 8: 369–373

    PubMed  Google Scholar 

  • Weil S, Vendola K, Zhou J, Bondy CA (1999) Androgen and folliclestimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 84 (8): 2951–2956

    Article  PubMed  CAS  Google Scholar 

  • Wiser A, Gonen O, Ghetler Y, Shavit T, Berkovitz A, Shulman A (2010) Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 25 (10): 2496–2500

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sektion für gynäkologische Endokrinologie und Reproduktionsmedizin, Universitätsklinikum Schleswig-Holstein Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck

    Prof. Dr. med. G. Griesinger

Authors
  1. Prof. Dr. med. G. Griesinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Schleswig-Holstein, Schleswig-Holstein, Campus Lübeck

    Klaus Diedrich  & Georg Griesinger  & 

  2. amedes, Zentrum für Endokrinologie, Kinderwunsch und Pränatale Medizin im Barkhof, Hamburg

    Michael Ludwig

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Griesinger, G. (2013). Behandlung der Patientin mit schlechtem Ansprechen auf die ovarielle Stimulation. In: Diedrich, K., Ludwig, M., Griesinger, G. (eds) Reproduktionsmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30181-0_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-30181-0_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-30180-3

  • Online ISBN: 978-3-642-30181-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation